Biodesix improved sales, cut losses in fourth quarter, fiscal 2024

Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, improved its top and bottom line results in the fourth quarter of 2024 and for the full fiscal year.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Already have a paid subscription?